Original Article
Hepatocellular Carcinoma Treatment With Sorafenib: Real-Life Evaluation of Prognostic Factors and a Practical Clue for Patient Management
Tratamento de Carcinoma Hepatocelular Com Sorafenib: Avaliação de Fatores de Prognóstico e um Indício Prático para a Orientação dos Doentes
Read
8283
Timeswas read the article
1219
Total PDF
7064
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 69 | 2 | 71 |
| 2025 11 | 158 | 16 | 174 |
| 2025 10 | 69 | 6 | 75 |
| 2025 9 | 97 | 11 | 108 |
| 2025 8 | 100 | 10 | 110 |
| 2025 7 | 145 | 8 | 153 |
| 2025 6 | 119 | 7 | 126 |
| 2025 5 | 116 | 1 | 117 |
| 2025 4 | 78 | 1 | 79 |
| 2025 3 | 104 | 5 | 109 |
| 2025 2 | 71 | 3 | 74 |
| 2025 1 | 70 | 8 | 78 |
| 2024 12 | 58 | 4 | 62 |
| 2024 11 | 57 | 6 | 63 |
| 2024 10 | 49 | 2 | 51 |
| 2024 9 | 72 | 11 | 83 |
| 2024 8 | 63 | 2 | 65 |
| 2024 7 | 102 | 7 | 109 |
| 2024 6 | 47 | 5 | 52 |
| 2024 5 | 71 | 7 | 78 |
| 2024 4 | 60 | 9 | 69 |
| 2024 3 | 113 | 6 | 119 |
| 2024 2 | 83 | 9 | 92 |
| 2024 1 | 126 | 10 | 136 |
| 2023 12 | 115 | 16 | 131 |
| 2023 11 | 153 | 13 | 166 |
| 2023 10 | 198 | 7 | 205 |
| 2023 9 | 107 | 8 | 115 |
| 2023 8 | 119 | 6 | 125 |
| 2023 7 | 87 | 8 | 95 |
| 2023 6 | 93 | 8 | 101 |
| 2023 5 | 142 | 8 | 150 |
| 2023 4 | 125 | 15 | 140 |
| 2023 3 | 139 | 13 | 152 |
| 2023 2 | 82 | 13 | 95 |
| 2023 1 | 88 | 6 | 94 |
| 2022 12 | 77 | 14 | 91 |
| 2022 11 | 70 | 14 | 84 |
| 2022 10 | 75 | 10 | 85 |
| 2022 9 | 95 | 12 | 107 |
| 2022 8 | 69 | 17 | 86 |
| 2022 7 | 45 | 12 | 57 |
| 2022 6 | 57 | 6 | 63 |
| 2022 5 | 36 | 4 | 40 |
| 2022 4 | 58 | 11 | 69 |
| 2022 3 | 92 | 8 | 100 |
| 2022 2 | 60 | 9 | 69 |
| 2022 1 | 74 | 13 | 87 |
| 2021 12 | 41 | 7 | 48 |
| 2021 11 | 84 | 7 | 91 |
| 2021 10 | 93 | 13 | 106 |
| 2021 9 | 84 | 13 | 97 |
| 2021 8 | 66 | 12 | 78 |
| 2021 7 | 57 | 14 | 71 |
| 2021 6 | 57 | 15 | 72 |
| 2021 5 | 63 | 12 | 75 |
| 2021 4 | 163 | 61 | 224 |
| 2021 3 | 111 | 11 | 122 |
| 2021 2 | 71 | 19 | 90 |
| 2021 1 | 69 | 14 | 83 |
| 2020 12 | 65 | 17 | 82 |
| 2020 11 | 80 | 8 | 88 |
| 2020 10 | 36 | 8 | 44 |
| 2020 9 | 37 | 7 | 44 |
| 2020 8 | 59 | 11 | 70 |
| 2020 7 | 42 | 8 | 50 |
| 2020 6 | 63 | 13 | 76 |
| 2020 5 | 64 | 6 | 70 |
| 2020 4 | 38 | 13 | 51 |
| 2020 3 | 39 | 10 | 49 |
| 2020 2 | 46 | 7 | 53 |
| 2020 1 | 47 | 8 | 55 |
| 2019 12 | 37 | 10 | 47 |
| 2019 11 | 37 | 8 | 45 |
| 2019 10 | 37 | 8 | 45 |
| 2019 9 | 50 | 7 | 57 |
| 2019 8 | 32 | 0 | 32 |
| 2019 7 | 30 | 7 | 37 |
| 2019 6 | 34 | 10 | 44 |
| 2019 5 | 87 | 6 | 93 |
| 2019 4 | 42 | 12 | 54 |
| 2019 3 | 51 | 7 | 58 |
| 2019 2 | 53 | 7 | 60 |
| 2019 1 | 31 | 4 | 35 |
| 2018 12 | 38 | 2 | 40 |
| 2018 11 | 32 | 4 | 36 |
| 2018 10 | 21 | 13 | 34 |
| 2018 9 | 13 | 4 | 17 |
| 2018 8 | 17 | 19 | 36 |
| 2018 7 | 24 | 15 | 39 |
| 2018 6 | 27 | 22 | 49 |
| 2018 5 | 14 | 10 | 24 |
| 2018 4 | 25 | 16 | 41 |
| 2018 3 | 42 | 19 | 61 |
| 2018 2 | 22 | 11 | 33 |
| 2018 1 | 8 | 15 | 23 |
| 2017 12 | 22 | 21 | 43 |
| 2017 11 | 11 | 5 | 16 |
| 2017 10 | 10 | 11 | 21 |
| 2017 9 | 10 | 14 | 24 |
| 2017 8 | 22 | 12 | 34 |
| 2017 7 | 17 | 8 | 25 |
| 2017 6 | 20 | 9 | 29 |
| 2017 5 | 16 | 8 | 24 |
| 2017 4 | 19 | 6 | 25 |
| 2017 3 | 18 | 9 | 27 |
| 2017 2 | 17 | 7 | 24 |
| 2017 1 | 14 | 10 | 24 |
| 2016 12 | 30 | 23 | 53 |
| 2016 11 | 35 | 33 | 68 |
| 2016 10 | 46 | 40 | 86 |
| 2016 9 | 21 | 30 | 51 |
| 2016 8 | 3 | 10 | 13 |
| 2016 7 | 1 | 6 | 7 |
Show all
